The role of p38 mitogen-activated protein kinase in IL-1β transcription

Journal of Immunology

Volumn 162, Issue 9, 1999, Pages 5367-5373

  Baldassare, Joseph J ^a   Bi, Yanhua ^a   Bellone, Clifford J ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; IMIDAZOLE DERIVATIVE; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; GENETIC TRANSCRIPTION; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; TRANSCRIPTION REGULATION;

ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CCAAT-ENHANCER-BINDING PROTEIN-DELTA; CCAAT-ENHANCER-BINDING PROTEINS; CELL LINE; CHLORAMPHENICOL O-ACETYLTRANSFERASE; DNA-BINDING PROTEINS; ENZYME ACTIVATION; ENZYME INHIBITORS; GENES, REPORTER; IMIDAZOLES; INTERLEUKIN-1; INTERLEUKIN-6; INTRACELLULAR FLUID; MACROPHAGES; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NUCLEAR PROTEINS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN SYNTHESIS INHIBITORS; PYRIDINES; RNA, MESSENGER; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 0033136947     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Schmidt, J. A., S. B. Mizel, D. Cohen, and I. Green. 1982. Interleukin-1, a potential regulatory of fibroblast proliferation. J. Immunol. 128:2177.
2. Romero, R., S. T. Parvizi, E. Oyarzun, M. Mazor, Y. K. Wu, C. Avila, A. P. Athanassiadis, and M. D. Mitchell. 1990. Amniotic fluid interleukin-1 in spontaneous labor at term. J. Reprod. Med. 35:235.
3. Espat, N. J., L. L. Moldawer, and E. Copeland III. 1995. Cytokine-mediated alterations in host metabolism prevent nutritional repletion in cachectic cancer patients. J. Surg. Oncol. 58:77.
4. Tocco-Bradley, R., M. Georgieff, C. T. Jones, L. L. Moldawer, C. A. Dinarello, G. L. Blackburn, and B. R. Bistrian. 1987. Changes in energy expenditure and fat metabolism in rats infused with interleukin-1. Eur. J. Clin. Invest. 17:504.
5. Krueger, J. M., J. Walter, C. A. Dinarello, S. M. Wolff, and L. Chedid. 1984. Sleep-promoting effects of endogenous pyrogen (interleukin 1). Am. J. Physiol. 246:994.
6. Firestein, G. S., and N. J. Zvaifler. 1991. Immunopathogenesis of rheumatoid arthritis. Immunol. Ser. 54:141.
7. Firestein, G. S. 1991. The Immunopathogenesis of rheumatoid arthritis. Curr. Opin. Rheum. 3:398.
8. Hess, E. V. 1990. Cytokine inhibitors and osteoarthritis. J. Rheum. 17:1123.
9. Hansson, G. K. 1993. Immune and inflammatory mechanisms in the development of atherosclerosis. Br. Heart J. 69:S38.
10. Nerup, J., T. Mandrup-Poulsen, J. Molvig, S. Helqvist, L. Wogensen, and J. Egeberg. 1988. Mechanisms of pancreatic β cell destruction in type I diabetes. Diabetes Care 11:16.
11. Deitch, E. A. 1992. Multiple organ failure: pathophysiology and potential future therapy. Ann. Surg. 216:117.
12. Hannum, C. H., C. J. Wilcox, W. P. Arend, F. G. Joslin, D. J. Dripps, P. L. Heimdal, L. G. Armes, A. Sommer, S. P. Eisenberg, and R. C. Thompson. 1990. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature 343:336.
13. Gershenwald, J. E., Y. M. Fong, T. J. Fahey, S. E. Calvano, R. Chizzonite, P. L. Kilian, S. R. Lowry, and L. L. Moldawer. 1990. Interleukin-1 receptor blockade attenuates the host inflammatory response. Proc. Natl. Acad. Sci. USA 13:4966.
14. Shapiro, L., and J. A. Gelfand. 1993. Cytokines and sepsis: pathophysiology and therapy. New Horiz. 1:13.
15. Dinarello, C. A., J. A. Gelfand, and S. M. Wolff. 1993. Anticytokine strategics in the treatment of the systemic inflammatory response syndrome. J. Am. Med. Assoc. 269:1829.
16. Knudsen, P. J., C. A. Dinarello, and T. B. Strom. 1986. Prostaglandins posttranscriptionally inhibit interleukin I activity by increasing intracellular cyclic adenosine monophosphate. J. Immunol. 137:3189.
17. DeForge, L. E., J. C. Fantone, J. S. Kenney, and D. G. Remick. 1992. Oxygen radical scavengers selectively inhibit interleukin 8 in human whole blood. J. Clin. Invest. 90:2123.
18. Essner, R., K. Rhoades, W. H. McBride, D. L. Morton, and J. S. Economou. 1989. IL-4 down regulates IL-1 and TNF gene expression in human monocytes. J. Immunol. 142:3857.
19. Moore, K., P. Vieira, D. Fiorentino, M. Troundstine, T. Khan, and T. Mosmann. 1990. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science 248:1230.
20. Lee, J. C., and J. L. Adams. 1995. Inhibitors of serine/threonine kinases. Curr. Opin. Biotechnol. 6:657.
21. Lee, J. C., and P. R. Young. 1996. Role of CSBP/p38/RK stress response kinase in LPS and cytokine signaling mechanisms. J. Leukocyte Biol. 59:152.
22. Lee, J. C., J. T. Laydon, P. C. McDonnell, T. F. Gallagher, S. Kumar, D. Green, D. McNulty, M. J. Blumenthal, J. R. Heys, S. W. Landvatter, et al. 1994. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372:739.
23. Young, P., P. McDonnell, D. Dunnington, A. Hand, J. Laydon, and J. Lee. 1993. Pyridinyl imidazoles inhibit IL-1 and TNF production at the protein level. Agents Actions 39.-C67.
24. Prichett, W., A. Hand, J. Sheilds, and D. Dunnington. 1995. Mechanism of action of bicyclic imidazoles defines a translational regulatory pathway for tumor necrosis factor α. J. Inflamm. 45:97.
25. Godambe, S. A., D. D. Chaplin, and C. J. Bellone. 1993. Regulation of IL-1 α and IL-1 βexpression in murine macrophages by lipopolysaccharide. Cytokine 5:327.
26. Godambe, S. A., D. D. Chaplin, T. Takova, and C. J. Bellone. 1994. An upstream NFIL-6-like site located within a DNase 1 hypersensitivity region mediates LPS-induced transcription of the murine IL-1β gene. J. Immunol. 153:143.
27. Godambe, S. A., D. D. Chaplin, T. Takova, and C. J. Bellone. 1995. A novel enhancer mediates LPS-induced transcription of the murine IL-1β gene. Mol. Cell. Biol. 15:112.
28. Godambe, S. A., D. D. Chaplin, T. Takova, and C. J. Bellone. 1994. An NFIL-6-like sequence near the transcriptional initiation start site is necessary for the LPS induction of murine interleukin-1B. DNA Cell Biol. 13:561.
29. Godambe, S. A., D. D. Chaplin, T. Takova, and C. J. Bellone. 1995. Molecular dissection of the murine IL-1 βpromoter. Am. J. Ther. 2:1.
30. Trautwein, C., C. Caelles, P. Van der Geer, T. Hunter, M. Karin, and M. Chojkier. 1993. Transactivation by NFIL-6/LAP is enhanced by phosphorylation of its activation domain. Nature 364:544.
31. Ray, A., and B. K. Ray. 1994. Serum amyloid a gene expression under acute-phase conditions involves participation of inducible C/EBP-δ and their activation by phosphorylation. Mol. Cell. Biol. 14:4324.
32. Wang, X. Z., and D. Ron. 1996. Stress-induced phosphorylalion and activation of the transcription factor CHOP (GADD153) by p38 MAPK. Science 272:1347.
33. Nishida, T., M. Takano, T. Kawakami, N. Nishino, S. Nakai, and Y. Hirai. 1988. The transcription of the interleukin 1 β gene is induced with PMA and inhibited with dexamethasone in U937 cells. Biochem. Biophys. Res. Commun. 156:269.
34. Hanson, R. D., N. L. Connolly, D. Burnett, E. J. Campbell, R. M. Senior, and T. J. Ley. 1990. Developmental regulation of the human cathepsin G gene in myelomonocytic cells. J. Biol. Chem. 265:1524.
35. Weber, J. D., D. M. Raben, P. J. Phillips, and J. J. Baldassare. 1997. Sustained activation of extracellular-signal-regulated kinase 1 (Erk 1) is required for the continued expression of cyclin D1 in G1 phase. Biochem. J. 326:61.
36. Gupta, S., D. Campbell, B. Derijard, and R. J. Davis. 1995. Transcription factor ATF2 regulation by the TNK signal transduction pathway. Science 267:389.
37. Badger, A. M., J. N. Bradbeer, B. Votta, J. C. Lee, J. L. Adams, and D. E. Griswold. 1996. Pharmacological profile of SB203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function. J. Pharmacol. Exp. Ther. 279:1453.
38. Larsen, J. K., I. A. Yamboliev, L. A. Weber, and W. T. Gerthoffer. 1997. Phosphorylation of the 27-kDa heat shock protein via p38 MAP kinase and MAPKAP kinase in smooth muscle. Am. J. Physiol. 273:L930.
39. Macfarlane, W. M., S. B. Smith, R. F. James, A. D. Clifton, Y. N. Doza, P. Cohen, and K. Docherty. 1997. The p38/reactivity kinase mitogen-activated protein kinase cascade mediates the activation of the transcription factor insulin upstream factor 1 and insulin gene transcription by high glucose in pancreatic β-cells. J. Biol. Chem. 272:20936.
40. Young, P. R., M. M. McLaughlin, S. Kumar, S. Kassis, M. L. Doyle, D. McNulty, T. F. Gallagher, S. Fisher, P. C. McDonnell, S. A. Carr, et al. 1997. Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP site. J. Biol. Chem. 272:12116.
41. Hiscott J., Marois J., J. Garoutalis, M. D'Addario, A. Roulston, I. Kwan, N. Pepin, J. N. Lacoste, H. Nguyen, G. Bensi, and M. Fenton. 1993. Characterization of a functional NF-κB site in the human interleukin 1 β promoter: evidence for a positive autoregulatory loop. Mol. Cell. Biol. 13:6231.
42. Davis, R. J. 1995. Transcriptional regulation by Map kinases. Mol. Reprod. Dev. 42:459.
43. Blasi, E., B. L. Mathieson, L. Varesio, J. L. Cleveland, P. A. Borchert, and U. R. Rapp. 1985. Selective immortalization of murine macrophages from fresh bone marrow by a raf/myc recombinant murine retrovirus. Nature 318:667.
44. Zhang, Y., and W. N. Rom. 1993. Regulation of the interleukin 1 β(IL-1β) gene by mycobacterial components and lipopolysaccharide is mediated by two nuclear factor-IL6 motifs. Mol. Cell. Biol. 13:3831.
45. Shirakawa, F., K. Saito, C. A. Bonagura, D. L. Galson, M. J. Fenton, A. C. Webb, and P. E. Auron. 1993. The human prointerleukin 1 β gene requires DNA sequences both proximal and distal to me transcription start site for tissue-specific induction. Mol. Cell. Biol. 13:1332.
46. Nakajima, T., S. Kinoshita, T. Sasagawa, K. Sasaki, M. Naruto, T. Kishimoto, and S. A. Kira. 1993. Phosphorylation at threonine-235 by a Ras-dependent mitogen-activated protein kinase C cascade is essential for transcription factor Nfil-6. Proc. Natl. Acad. Sci. USA 90:2207.
47. Twamley-Stein, G., E. Kowenz-Leutz, S. Ansieau, and A. Leutz. 1996. Regulation of C/EBP β/NF-M activity by kinase oncogenes. Curr. Top. Microbiol. Immunol. 211:129.
48. Margulies, L., and P. B. Sehgal. 1993. Modulation of the human interleukin-6 promoter (IL-6) and transcription factor C/EBPβ (NF-IL6) activity by p53 species. J. Biol. Chem. 268:15096.
49. Kominato, Y., D. Galson, W. R. Waterman, A. C. Webb, and P. E. Auron. 1995. Monocyte expression of the human prointerleukin 1 β gene (IL1B) is dependent on promoter sequences which bind the hematopoietic transcription factor Spi-1/PU.I. Mol. Cell. Biol. 15:59.
50. Hiscott, J., J. Marois, J. Garoutalis, M. D'Addario, A. Reulston, I. Kwan, N. Pepin, J. N. Lacoste, H. Nguyen, G. Bensi, and M. Fenton. 1993. Characterization of a functional NF-κB site in the human interleukin-1 β promoter: evidence for a positive autoregulatory loop. Mol. Cell. Biol. 13:6231.
51. Gray, J. G., G. Chandra, W. C. Clay, S. W. Stinnet, S. A. Hanneline, J. J. Lorenz, I. R. Patel, G. Wisely, P. J. Purdon, D. Taylor, and T. A. Kost. 1993. A CRE/ATF-like site in the upstream regulatory sequence of the human interleukin-1 β gene is necessary for induction of U937 and Thp-1 monocyte cell lines. Mol. Cell. Biol. 13:6678.
52. Ulevitch, R. J., D. L. Dunn, M. P. Fink, and C. E. Taylor. 1996. Endotoxin-related intracellular pathways: implications for therapeutic intervention. Shock 6:1.
53. Lodie, T. A., R. Savedra, Jr., D. T. Golenbock, C. P. Van Beveren, R. A. Maki, and M. J. Fenton. 1997. Stimulation of macrophages by lipopolysaccharide alters the phosphorylation state, conformation, and function of PU.I via activation of casein kinase II. J. Immunol. 158:1848.
54. Davis, R. J. 1998. Transcriptional regulation by MAP kinases. Mol. Reprod. Dev. 42:459.